Blog
Menopause & MASLD
Women who experience menopause prior to the age of 50 are at increased risk of metabolic dysfunction-associated steatotic liver disease (MASLD), as well as coexisting risk factors such as prediabetes, obesity, high blood pressure, and abnormal lipid levels in the...
Efruxifermin Study
The New England Journal of Medicine recently published a study titled "Efruxifermin in Compensated Liver Cirrhosis Caused by MASH" on May 7, 2025. This phase 3 clinical trial evaluated the efficacy and safety of efruxifermin, a fibroblast growth factor 21 (FGF21)...
Miniature, functional liver models are here
In a study published in Nature, Keio University researchers unveiled a method to proliferate these hard-to-grow organoids by a million-fold in just 3–4 weeks while maintaining key liver functions. "These organoids are potentially the closest...
